There is limited knowledge of leishmaniasis in West Africa including the environmental factors affecting this disease, the role of vector saliva in leishmaniasis and the role of other pathogens in the development of this neglected disease. Recent studies in Mali and Ghana enabled us to formulate more comprehensive quesfions and propose new hypothesis to increase our understanding of the transmission and development of cutaneous leishmaniasis in the field with the objecfive to idenfify novel ways to prevent and treat this neglected disease. The major specific aim of this proposal is to: understand the associafion of immune responses of individuals living in endemic areas to vector salivary proteins in the development of leishmaniasis and importantly, how these immune responses may be modulated by co-infections with filarial worms. Findings of these study will contribute to guide vaccine development based on salivary gland proteins. The long-term objectives of the Administrative Core are to: 1] develop expertise in research administration for each institufion involved, 2] provide leadership on administrative issues related to health research, and 3] to contribute in the training of individuals (capacity building) to ensure self-sustaining research and networks on neglected tropical diseases with other Tropical Medicine Research Center. More specifically, the administrafive core will 1] Track scientific progress and accomplishments for each of the individual projects and cores;2] Identify and ensure the coordinafion of related studies at different field sites and laboratories;3] Ensure compliance with IRBs and other regulatory authorifies for studies of human subjects;4] Develop administrafive guidelines to define the responsibilifies of investigators, and to ensure the responsible management of funds provided for these studies.

Public Health Relevance

This proposal is relevant to publich health at it will contribute to the development of a potenfial new vaccine against cutaneous leishmaniasis, which is endemic in many poor countries.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
1P50AI098505-01
Application #
8304446
Study Section
Special Emphasis Panel (ZAI1-AWA-M (J1))
Project Start
Project End
2013-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$57,579
Indirect Cost
$4,265
Name
University of Bamako
Department
Type
DUNS #
565539819
City
Bamako
State
Country
Mali
Zip Code
BP E2-528
Sangare, Moussa Brema; Coulibaly, Yaya Ibrahim; Coulibaly, Siaka Yamoussa et al. (2018) A cross-sectional study of the filarial and Leishmania co-endemicity in two ecologically distinct settings in Mali. Parasit Vectors 11:18
Coulibaly, Cheick Amadou; Traore, Bourama; Dicko, Adama et al. (2018) Impact of insecticide-treated bednets and indoor residual spraying in controlling populations of Phlebotomus duboscqi, the vector of Leishmania major in Central Mali. Parasit Vectors 11:345
Touré, Mahamoudou; Petersen, Pelle T; Bathily, Sidy N'd et al. (2017) Molecular Evidence of Malaria and Zoonotic Diseases Among Rapid Diagnostic Test-Negative Febrile Patients in Low-Transmission Season, Mali. Am J Trop Med Hyg 96:335-337
Traoré, Bourama; Oliveira, Fabiano; Faye, Ousmane et al. (2017) Correction: Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali. PLoS Negl Trop Dis 11:e0005379
Coulibaly, C A; Sissoko, I; Traore, B et al. (2016) Diversity of Sand Flies (Diptera: Psychodidae: Phlebotominae) in Two Different Eco-Climatic and Endemic Zones of Cutaneous Leishmaniasis in Mali, West Africa. J Med Entomol 53:923-927
Traoré, Bourama; Oliveira, Fabiano; Faye, Ousmane et al. (2016) Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali. PLoS Negl Trop Dis 10:e0005141
Wei, Stanley C; Vanden Eng, Jodi L; Patterson, Amy E et al. (2012) Validity of Expanded Program on Immunization Contact Method health behavior estimates in Mali. J Infect Dis 205 Suppl 1:S112-9